1. Home
  2. LGL vs PMN Comparison

LGL vs PMN Comparison

Compare LGL & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGL
  • PMN
  • Stock Information
  • Founded
  • LGL 1917
  • PMN 2004
  • Country
  • LGL United States
  • PMN Canada
  • Employees
  • LGL N/A
  • PMN N/A
  • Industry
  • LGL Industrial Machinery/Components
  • PMN Pharmaceuticals and Biotechnology
  • Sector
  • LGL Technology
  • PMN Health Care
  • Exchange
  • LGL Nasdaq
  • PMN Nasdaq
  • Market Cap
  • LGL 31.5M
  • PMN 29.8M
  • IPO Year
  • LGL N/A
  • PMN N/A
  • Fundamental
  • Price
  • LGL $6.67
  • PMN $0.95
  • Analyst Decision
  • LGL
  • PMN
  • Analyst Count
  • LGL 0
  • PMN 0
  • Target Price
  • LGL N/A
  • PMN N/A
  • AVG Volume (30 Days)
  • LGL 3.7K
  • PMN 43.9K
  • Earning Date
  • LGL 03-31-2025
  • PMN 03-31-2025
  • Dividend Yield
  • LGL N/A
  • PMN N/A
  • EPS Growth
  • LGL 66.76
  • PMN N/A
  • EPS
  • LGL 0.07
  • PMN N/A
  • Revenue
  • LGL $4,130,000.00
  • PMN N/A
  • Revenue This Year
  • LGL N/A
  • PMN N/A
  • Revenue Next Year
  • LGL N/A
  • PMN N/A
  • P/E Ratio
  • LGL $98.09
  • PMN N/A
  • Revenue Growth
  • LGL 26.49
  • PMN N/A
  • 52 Week Low
  • LGL $4.86
  • PMN $0.87
  • 52 Week High
  • LGL $7.35
  • PMN $2.61
  • Technical
  • Relative Strength Index (RSI)
  • LGL 51.07
  • PMN 52.16
  • Support Level
  • LGL $6.50
  • PMN $0.88
  • Resistance Level
  • LGL $6.89
  • PMN $1.03
  • Average True Range (ATR)
  • LGL 0.25
  • PMN 0.06
  • MACD
  • LGL -0.03
  • PMN 0.00
  • Stochastic Oscillator
  • LGL 56.00
  • PMN 46.67

About LGL LGL Group Inc. (The)

LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: